Financials data is unavailable for this security.
View more
Year on year net income at Sanofi SA changed little (from 5.40bn to 5.56bn) despite revenues that grew 6.41%.
Gross margin | 70.94% |
---|---|
Net profit margin | 13.59% |
Operating margin | 18.38% |
Return on assets | -- |
---|---|
Return on equity | -- |
Return on investment | -- |
More ▼
Cash flow in EURView more
In 2024, cash reserves at Sanofi SA fell by 1.27bn. However, the company earned 8.91bn from its operations for a Cash Flow Margin of 20.13%. In addition the company used 4.41bn on investing activities and also paid 5.76bn in financing cash flows.
Cash flow per share | 3.65 |
---|---|
Price/Cash flow per share | 13.08 |
Book value per share | 34.53 |
---|---|
Tangible book value per share | 4.79 |
More ▼
Balance sheet in EURView more
Current ratio | 1.37 |
---|---|
Quick ratio | 0.688 |
Total debt/total equity | 0.2841 |
---|---|
Total debt/total capital | 0.2205 |
More ▼
Growth rates in EUR
SmartText is unavailable
EPS growth(5 years) | 14.01 |
---|---|
EPS (TTM) vs TTM 1 year ago | 54.42 |